Compare Novavax Inc (NVAX) vs Simon Property Group Inc (SPG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs Simon Property Group Inc — how do they compare? Novavax Inc trades at $8.08 (market cap $1.30B), while Simon Property Group Inc trades at $227 (market cap $74.00B). The key difference: Simon Property Group Inc is far larger — about 56.9× Novavax Inc's market cap, and Simon Property Group Inc pays a 3.86% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.
| NVAX | SPG | |
|---|---|---|
Market Cap | $1.30B | $74.00B |
Sector | Health | Real Estate |
52-Week High | $11.19 | $228.70 |
52-Week Low | $6.22 | $160.68 |
Enterprise Value | $800.50M | $102.48B |
Dividend Yield | — | 3.86% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About Simon Property Group Inc
Simon Property Group is the second- largest real estate investment trust in the United States. Its portfolio includes an interest in 207 properties: 119 traditional malls, 69 premium outlets, 14 Mills centers (a combination of a traditional mall, outlet center, and big-box retailers), six lifestyle centers, and five other retail properties. Simon's portfolio averaged $693 in sales per square foot over the 12 months prior to the pandemic. The company also owns a 21% interest in Klepierre, a European retail company with investments in shopping centers in 16 countries, and joint venture interests in 33 premium outlets across 11 countries.
Read more on SPG →
